News from the New York Node: NIDA Lifetime Achievement Award for Dr. John Rotrosen

The New York Node is proud to announce that Dr. John Rotrosen, MD, an esteemed and long-time member of the CTN, has been presented the Lifetime Achievement Award by the National Institute on Drug Abuse (NIDA), in recognition of his unwavering commitment to the advancement of translational research in the area of substance use and other psychiatric disorders.

This distinguished honor recognizes his outstanding contributions advancing science that improves lives. Dr. Rotrosen’s contributions to addiction, ADHD, schizophrenia, and movement disorders research have made a significant impact on public health, including the development of atypical antipsychotics, innovative drug delivery methods, and new treatments for SUDs.

As a principal investigator for major NIDA and Veterans Administration initiatives, he has led seminal clinical trials and medication development projects using innovative and elegant approaches that leveraged clinical genetics, neuroimaging, and healthcare services research to help bridge the gap between scientific discovery and real-world medical practice, improving addiction treatment accessibility and outcomes. Dr. Rotrosen’s work has not only made a significant impact on the field of addiction but has also inspired and influenced countless individuals in the research community and society at large.

Dr. Rotrosen retired in October 2023, after being with the CTN since its inception in 2000. Read more about his retirement here.

Congratulations, Dr. Rotrosen!